In today’s briefing:
- Weekly Deals Digest (28 Sep) – Zijin Gold, Tekscend, Mandom, Pacific Ind, Paramount Bed, Soft99
- Buys Focused in China, Taiwan, and Korea; Bullish Outlook Intact
- China Healthcare Weekly (Sep.28) – Trump’s Pharma Tariff, Companies Increase Their Holdings, Duality
Weekly Deals Digest (28 Sep) – Zijin Gold, Tekscend, Mandom, Pacific Ind, Paramount Bed, Soft99
- A weekly summary of key developments across ECM and Event-Driven names tracked by us across Hong Kong, Australia, New Zealand, Singapore, Japan, Indonesia, Malaysia, Thailand, Korea, India and Chinese ADRs.
- ECM developments: Zijin Gold (2259 HK), Tekscend Photomask (429A JP) and Tata Capital Limited (TATACAP IN) IPOs.
- Event-Driven developments: Mandom Corp (4917 JP), Pacific Industrial (7250 JP), Paramount Bed Holdings Co Lt (7817 JP), Soft99 Corp (4464 JP), Changhong Jiahua Holdings (3991 HK).
Buys Focused in China, Taiwan, and Korea; Bullish Outlook Intact
- We remain near-term bullish since our 4/22/25 Compass, and our intermediate-term outlook remains bullish as well (as of our 5/14/25 Compass), with Int’l Compass reports all echoing this sentiment.
- Market dynamics remain overwhelmingly risk-on; with plenty of global liquidity, we expect upside to continue into year-end and the early part of 2026.
- Remain Overweight Taiwan, China, Korea, U.S., and Greece. Many buys in these countries, and also Europe and Japan. EURO STOXX 50 on the cusp of major breakout above 5500
China Healthcare Weekly (Sep.28) – Trump’s Pharma Tariff, Companies Increase Their Holdings, Duality
- Trump said he will place import taxes on 100% of pharmaceutical drugs, which will begin on Oct.1. Below, we shared our views on this new policy.
- Some companies continue to repurchase/increase their holdings despite the industry’s significant rise this year, indicating that major shareholders truly have confidence in the outlook. We specifically listed these companies.
- The fluctuations in Duality’s stock price are obviously driven by capital after being included in HK Stock Connect. we suggest that investors pay attention to risks as Duality faces correction.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
